Actively Recruiting

Phase 4
Age: 18Years - 75Years
All Genders
NCT06485726

Valproate Versus Propranolol in Migraine

Led by Kafrelsheikh University · Updated on 2024-07-03

600

Participants Needed

1

Research Sites

75 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Investigators aim to compare the effect of valproate versus propranolol in migraine by assessing the absolute reduction in MMD in each group and the percentage of patients who achieved ≥ 50% reduction in the monthly headache days frequency compared to the baseline frequency.

CONDITIONS

Official Title

Valproate Versus Propranolol in Migraine

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Naive migraine patients diagnosed according to the International Classification of Headache Disorders 3rd edition
  • Aged between 18 and 75 years
Not Eligible

You will not qualify if you...

  • Patients with major neurological disorders such as epilepsy, ischemic or hemorrhagic stroke, multiple sclerosis, mitochondrial diseases, brain tumors, or essential tremors
  • Patients with major systemic diseases including malignancy, collagen, liver, or renal diseases
  • Patients with cardiovascular diseases such as hypertension (systolic >130 or diastolic >85 mm/Hg on at least three occasions), diabetes (fasting glucose >126 mg/dl, casual glucose >200 mg/dl, or HbA1C >6.5)
  • Patients with valvular or ischemic heart diseases, bradycardia or heart blocks, congestive heart failure
  • Patients who have received prophylactic treatment for migraine
  • Patients with contraindications to the study drugs
  • Patients with bronchial asthma or chronic obstructive pulmonary disease

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Kafr Elsheikh University Hospital

Kafr ash Shaykh, Egypt, 33511

Actively Recruiting

Loading map...

Research Team

M

mohamed G. Zeinhom, MD

CONTACT

S

sherihan R. ahmed, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here